ATA240692A - Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat - Google Patents
Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitratInfo
- Publication number
- ATA240692A ATA240692A AT0240692A AT240692A ATA240692A AT A240692 A ATA240692 A AT A240692A AT 0240692 A AT0240692 A AT 0240692A AT 240692 A AT240692 A AT 240692A AT A240692 A ATA240692 A AT A240692A
- Authority
- AT
- Austria
- Prior art keywords
- ranitide
- inismutcitrate
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919126027A GB9126027D0 (en) | 1991-12-06 | 1991-12-06 | Medicaments |
GB929206083A GB9206083D0 (en) | 1992-03-20 | 1992-03-20 | Medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA240692A true ATA240692A (de) | 1996-02-15 |
AT401468B AT401468B (de) | 1996-09-25 |
Family
ID=26299971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0240692A AT401468B (de) | 1991-12-06 | 1992-12-04 | Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat |
Country Status (26)
Country | Link |
---|---|
US (1) | US5466436A (de) |
EP (1) | EP0550083B1 (de) |
JP (1) | JPH05246853A (de) |
KR (1) | KR930009605A (de) |
AP (1) | AP324A (de) |
AT (1) | AT401468B (de) |
AU (1) | AU664574B2 (de) |
BE (1) | BE1007268A3 (de) |
CA (1) | CA2084568A1 (de) |
CH (1) | CH685537A5 (de) |
CZ (1) | CZ358092A3 (de) |
DE (1) | DE69228738D1 (de) |
DK (1) | DK0550083T3 (de) |
ES (1) | ES2130152T3 (de) |
FR (1) | FR2684554B1 (de) |
GB (1) | GB2262036B (de) |
GR (1) | GR3030426T3 (de) |
IE (1) | IE922866A1 (de) |
IL (1) | IL103978A (de) |
IT (1) | IT1256697B (de) |
LU (1) | LU88196A1 (de) |
MX (1) | MX9207008A (de) |
MY (1) | MY108146A (de) |
NO (1) | NO303670B1 (de) |
NZ (1) | NZ245365A (de) |
PH (1) | PH31380A (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6117412A (en) * | 1995-01-26 | 2000-09-12 | Nycomed Imaging As | Non-cluster type bismuth compounds |
GB9501560D0 (en) | 1995-01-26 | 1995-03-15 | Nycomed Imaging As | Contrast agents |
WO1998022117A1 (en) * | 1996-11-22 | 1998-05-28 | The Procter & Gamble Company | Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials |
WO1998022118A1 (en) * | 1996-11-22 | 1998-05-28 | The Procter & Gamble Company | Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid |
SE0000773D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
SE0000774D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
EE05234B1 (et) * | 2001-03-08 | 2009-12-15 | Astrazeneca Ab | 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi vltimiseks |
MXPA03011017A (es) | 2001-06-01 | 2005-04-29 | Pozen Inc | Composiciones farmaceuticas para la entrega coordinada de nsaids. |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
SE0102993D0 (sv) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
US20080020040A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Unit dose form for administration of ibuprofen |
US8067451B2 (en) * | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
US20080021078A1 (en) * | 2006-07-18 | 2008-01-24 | Horizon Therapeutics, Inc. | Methods and medicaments for administration of ibuprofen |
JP2009501801A (ja) * | 2005-07-18 | 2009-01-22 | ホライゾン セラピューティクス, インコーポレイテッド | イブプロフェンとファモチジンとを含有する医薬およびその投与 |
US8067033B2 (en) | 2007-11-30 | 2011-11-29 | Horizon Pharma Usa, Inc. | Stable compositions of famotidine and ibuprofen |
WO2008027963A2 (en) * | 2006-08-31 | 2008-03-06 | Horizon Therapeutics, Inc. | Nsaid dose unit formulations with h2-receptor antagonists and methods of use |
EP2344139A1 (de) | 2008-09-09 | 2011-07-20 | AstraZeneca AB | Verfahren zur abgabe einer pharmazeutischen zusammensetzung an einen patienten, der diese benötigt |
EA201290026A1 (ru) | 2009-06-25 | 2012-07-30 | Астразенека Аб | Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid) |
BR112014016085A8 (pt) | 2011-12-28 | 2017-07-04 | Pozen Inc | composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico |
CN110893233A (zh) * | 2019-12-19 | 2020-03-20 | 川北医学院附属医院 | 一种鸢尾素在制备抗炎药物中的应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4464679A (en) * | 1981-07-06 | 1984-08-07 | Rca Corporation | Method and apparatus for operating a microprocessor in synchronism with a video signal |
GB2105193B (en) * | 1981-09-04 | 1984-09-12 | Glaxo Group Ltd | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents |
SE8302689L (sv) * | 1982-05-14 | 1983-11-15 | Richter Gedeon Vegyeszet | Farmaceutiska kompositioner innehallande flera aktiva bestandsdelar |
US4757060A (en) * | 1986-03-04 | 1988-07-12 | Bristol-Myers Company | Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers |
GB8625325D0 (en) * | 1986-10-22 | 1986-11-26 | Glaxo Group Ltd | Chemical compounds |
EP0282132B1 (de) * | 1987-03-09 | 1992-09-30 | The Procter & Gamble Company | Zusammensetzungen und ihre Verwendung zur Behandlung von Magen-Darmstörungen |
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
CH679582A5 (de) * | 1988-07-18 | 1992-03-13 | Glaxo Group Ltd | |
NZ235877A (en) * | 1989-11-02 | 1992-09-25 | Mcneil Ppc Inc | Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence |
GB9019875D0 (en) * | 1990-09-11 | 1990-10-24 | Glaxo Group Ltd | Pharmaceutical compositions |
US5128140A (en) * | 1991-01-14 | 1992-07-07 | The Procter & Gamble Company | Swallowable pharmaceutical compositions |
-
1992
- 1992-11-27 DE DE69228738T patent/DE69228738D1/de not_active Expired - Lifetime
- 1992-11-27 ES ES92203674T patent/ES2130152T3/es not_active Expired - Lifetime
- 1992-11-27 EP EP92203674A patent/EP0550083B1/de not_active Expired - Lifetime
- 1992-11-27 DK DK92203674T patent/DK0550083T3/da active
- 1992-12-02 GB GB9225174A patent/GB2262036B/en not_active Expired - Fee Related
- 1992-12-03 PH PH45371A patent/PH31380A/en unknown
- 1992-12-04 AP APAP/P/1992/000453A patent/AP324A/en active
- 1992-12-04 MY MYPI92002235A patent/MY108146A/en unknown
- 1992-12-04 NZ NZ245365A patent/NZ245365A/en unknown
- 1992-12-04 IL IL103978A patent/IL103978A/en not_active IP Right Cessation
- 1992-12-04 MX MX9207008A patent/MX9207008A/es not_active IP Right Cessation
- 1992-12-04 KR KR1019920023309A patent/KR930009605A/ko not_active Application Discontinuation
- 1992-12-04 JP JP4325308A patent/JPH05246853A/ja active Pending
- 1992-12-04 NO NO924704A patent/NO303670B1/no unknown
- 1992-12-04 CH CH3737/92A patent/CH685537A5/fr unknown
- 1992-12-04 IE IE286692A patent/IE922866A1/en not_active Application Discontinuation
- 1992-12-04 BE BE9201070A patent/BE1007268A3/fr not_active IP Right Cessation
- 1992-12-04 IT ITRM920869A patent/IT1256697B/it active IP Right Grant
- 1992-12-04 CA CA002084568A patent/CA2084568A1/en not_active Abandoned
- 1992-12-04 AU AU29863/92A patent/AU664574B2/en not_active Ceased
- 1992-12-04 CZ CS923580A patent/CZ358092A3/cs unknown
- 1992-12-04 LU LU88196A patent/LU88196A1/fr unknown
- 1992-12-04 FR FR9214642A patent/FR2684554B1/fr not_active Expired - Fee Related
- 1992-12-04 AT AT0240692A patent/AT401468B/de not_active IP Right Cessation
-
1993
- 1993-12-17 US US08/168,231 patent/US5466436A/en not_active Expired - Fee Related
-
1999
- 1999-06-04 GR GR990401510T patent/GR3030426T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA129892A (de) | Pharmazeutische zusammensetzung | |
DE4291156T1 (de) | Verbesserte pharmazeutische Zusammensetzungen | |
FI981777A0 (fi) | Farmaseuttinen ainekoostumus | |
ATE203400T1 (de) | Pharmazeutische formulierungen | |
PT589843E (pt) | Composicoes farmaceuticas contendo ciclosporinas | |
DE10199066I1 (de) | Pharmazeutische Zusammensetzung | |
ATA240692A (de) | Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat | |
DK0515312T3 (da) | Farmaceutisk præparat | |
FI921060A (fi) | Farmaceutiska aerosolformuleringar | |
FI923581A (fi) | Farmaceutisk kombinationsformation | |
BR9200058A (pt) | Composto e composicao farmaceutica | |
ITRM910952A0 (it) | Composizioni farmaceutiche contenenti gonadotropine | |
ITMI921123A0 (it) | Formulazioni farmaceutiche orali contenenti antocianosidi | |
MX9200622A (es) | Composicion farmaceutica | |
DE4294862T1 (de) | Pharmazeutische Komposition | |
GB2251617B (en) | Pharmaceutical compositions containing substituted 3-hydroxypyridin-4-ones | |
DE69122229T2 (de) | Penciclovir enthaltende pharmazeutische formulierung | |
FI952377A0 (fi) | Farmaseuttisia ibuprofeenikoostumuksia | |
FI934387A0 (fi) | 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner | |
DE68902056T2 (de) | 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung. | |
ITMI912766A1 (it) | Composizione farmaceutica contenente n-acetil-cisteina | |
ATA31798A (de) | Pharmazeutische zusammensetzung enthaltend ciclosporin | |
SE9101348D0 (sv) | Pharmaceutical composition | |
SE9103213D0 (sv) | Farmaceutisk komposition | |
LV5728B4 (lv) | Farmaceitiskas kompozicijas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |